Discover how our digital and molecular sample bank can advance your spatial biology algorithm development. https://lnkd.in/d3KuUzay #AI #Digitalpathology
Genomic Testing Cooperative
生物技术研究
Lake Forest，California 2,871 位关注者
Making Genomics Available and Affordable for Everyone
关于我们
Our Mission is to create a diagnostic service that provides access to advanced genomic testing in communities everywhere. Our testing provides answers for ALL cancers covering both solid tumors and hematologic neoplasms. Genomic Testing Cooperative (GTC) is a different kind of cancer diagnostic laboratory. Our cooperative model allows us to partner with laboratories, hospitals, oncology practices and medical professionals to share resources which create efficiencies in cost, turnaround time and quality. In creating a network of Co-Op partners, we help get results to physicians faster, share knowledge and generate better outcomes for patients.
- 网站
-
https://genomictestingcooperative.com
Genomic Testing Cooperative的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Lake Forest，California
- 类型
- 私人持股
- 创立
- 2018
- 领域
- Genomic testing、Precision Medicine、Next Gen Sequencing、Oncology、Hematology、Comprehensive Genomic Profiling、Leukemia、Lymphoma、Myeloma、Lung Cancer、Breast Cancer、Colon Cancer和CDx
地点
-
主要
获取路线
25371 Commercentre Dr
US，California，Lake Forest，92630
Genomic Testing Cooperative员工
-
Jeffrey Owen
Vice President, Marketing @ Genomic Testing Cooperative
-
Rachel Rosenberger
Lead Clinical Data Reporter at Genomic Testing Cooperative
-
Maher Albitar
Founder, Chief Executive Officer and Chief Medical Officer at Genomic Testing Cooperative
-
Jennifer Varca
Vice President, Business Development
动态
-
Two critical pieces of information GTC's Hematology Profile Plus and Liquid Trace Hematology provide are: - RNA sequencing allows identification of fusions and gene overexpression of important myeloma prognostic factors including - When NSD2 fusion is detected, we distinguish between early vs late disruption of NSD2 gene, which has prognostic implications https://lnkd.in/dWGyJYW6 #RNA #Multiplemyeolma #NSD2
-
-
Don’t let QNS/TNP fears stop you from ordering comprehensive genomic profiling. Using innovative chemistry helps reduce QNS and TNP rates. GTC's QNS rate is currently less than 1%. Most labs using NGS are greater than >10% QNS/TNP Read more: https://lnkd.in/gBmGD6u #GenomicTestingCooperative #QNS #ComprehensiveGenomicProfiling #PrecisionMedicine #CancerDiagnosis
-
-
Check out our publications on RNA and cfRNA to see how GTC us innovating in this rapidly developing area of genomics. https://lnkd.in/d5pyUw_w #RNA #cfRNA #geneexpression
-
-
CSF is a very good source of liquid biopsies in primary and metastatic brain tumors. ? Provides a better yield than plasma for detection of tumor-derived genomic material. ? Alternative to evaluate patients who can’t undergo a brain biopsy. ? It enables us to quantify tumor in the CNS https://lnkd.in/duiFUP8F #CSF #Glioblastoma #liquidbiopsy
-
-
One example is how GTC's Hematology Profile Plus and Liquid Trace Hematology can detect?AML with KMT2A-PTD. KMT2A partial tandem duplication that spans exons 2 through 8-10, which we are able to identify by evaluating copy number variation over the whole length of the gene. Learn more:?https://lnkd.in/dWGyJYW6 #RNA #KMT2A #CNV
-
-
It's Breast Cancer Awareness Month! We'd like to take a moment to bring awareness to the importance of comprehensive biomarker testing to provide optimal treatment. Breast cancer has numerous actionable biomarkers including TMB, HRR,?HRD,?HER2, BRCA1/2, PI3CA, ESR1 and more. Don't accept partial results! Learn more:?https://lnkd.in/d8NzX7b #Breastcancerawareness #BRCA1 #PIK3CA #ESR1 #HER2?
-
-
Check out GTC's new billing page. https://lnkd.in/dzuK_fPj
-
-
Catch GTC at the upcoming APM meeting where we will be speaking on:?Transcriptomics and AI in Transforming Precision Diagnosis?with Dr. Maher Albitar, Dr. Andrew Pecora and Dr. Marije Balic. https://lnkd.in/gysRzxe #RNA #Transcriptomics #AI
-
-
Every aspect of GTC's assays has been perfected through testing thousands of samples. Each aspect of our assays was designed based on the latest understanding of tumor biology and incorporate powerful analysis tools to detect all kinds of genomic abnormalities. https://lnkd.in/gBmGD6u #RNA #Geneexpression #Alternativesplicing?
-